Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 20.17
+0.32 (1.61%)
At close: Jan 23, 2026
Sansure Biotech Revenue
Sansure Biotech had revenue of 375.52M CNY in the quarter ending September 30, 2025, with 18.98% growth. This brings the company's revenue in the last twelve months to 1.67B, up 18.65% year-over-year. In the year 2024, Sansure Biotech had annual revenue of 1.46B with 44.78% growth.
Revenue (ttm)
1.67B
Revenue Growth
+18.65%
P/S Ratio
6.94
Revenue / Employee
711.69K
Employees
2,346
Market Cap
11.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.46B | 450.94M | 44.78% |
| Dec 31, 2023 | 1.01B | -5.44B | -84.39% |
| Dec 31, 2022 | 6.45B | 1.94B | 42.88% |
| Dec 31, 2021 | 4.51B | -248.42M | -5.22% |
| Dec 31, 2020 | 4.76B | 4.40B | 1,203.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Truking Technology | 5.55B |
| Tofflon Science and Technology Group | 5.22B |
| Allmed Medical Products Co.,Ltd | 3.47B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.12B |
| Autek China | 1.82B |
| Andon Health | 1.57B |
| Eyebright Medical Technology (Beijing) | 1.48B |
| Mingyue Optical Lens | 813.39M |